Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02469532 · ClinicalTrials.gov registry record
DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes
A clinical trial, sponsored by Mercator MedSystems.
- Completed
- Registry status
- 31
- Enrollment target
NCT02469532: Completed study, sponsored by Mercator MedSystems.
NCT02469532 is a clinical trial that has completed, run by Mercator MedSystems. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02469532 has completed, sponsored by Mercator MedSystems.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, observational registry to document the baseline, 24-hour and 30-day inflammatory response and procedural outcomes out to 12 month follow-up after femoropopliteal angioplasty or atherectomy-based revascularization procedures.
Primary Outcome
Change in inflammatory biomarkers (hs-CRP, MCP-1 and MMP-9) from baseline to 24 hours post-procedure and 30-days post-revascularization procedure.
Interventions
- DEVICE Balloon Angioplasty
- DEVICE Atherectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-01 |
What the finished NCT02469532 record still lists
NCT02469532 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Balloon Angioplasty is the first listed.
NCT02469532 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02469532 about?
NCT02469532 is a clinical study titled "DANCE Partner: Inflammatory Biomarker Analysis by Femoropopliteal Revascularization Method and Treatment Outcomes". This is a prospective, multi-center, observational registry to document the baseline, 24-hour and 30-day inflammatory response and procedural outcomes out to 12 month follow-up after femoropopliteal angioplasty or atherectomy-based revascularization procedures.
What is the current status of trial NCT02469532?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2015-05. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02469532?
The interventions under investigation include: Balloon Angioplasty (DEVICE), Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT02469532?
This trial is sponsored by Mercator MedSystems, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia